CALL/ROCHE GS/250/0.1/20.12.24 Share Price

Warrant

DE000GZ6BSQ5

Real-time BOERSE MUENCHEN 03:55:04 18/07/2024 pm IST
3.28 EUR +0.92% Intraday chart for CALL/ROCHE GS/250/0.1/20.12.24
Current month+130.50%
1 month+142.54%
Date Price Change
18/24/18 3.28 +0.92%
17/24/17 3.25 +66.67%
16/24/16 1.95 +0.52%
15/24/15 1.94 +14.79%
12/24/12 1.69 +13.42%

Real-time BOERSE MUENCHEN

Last update July 18, 2024 at 03:55 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Goldman Sachs
WKN GZ6BSQ
ISINDE000GZ6BSQ5
Date issued 29/12/2022
Strike 250 CHF
Maturity 20/12/2024 (155 Days)
Parity 10 : 1
Emission price 5.02
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.45
Lowest since issue 0.322
Spread 0.07
Spread %2.09%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
274 CHF
Average target price
274 CHF
Spread / Average Target
0.00%
Consensus